Growing community of inventors

Ballerup, Denmark

Jens Larsen

Average Co-Inventor Count = 2.07

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 20

Jens LarsenSimon Feldbaek Nielsen (3 patents)Jens LarsenXifu Liang (3 patents)Jens LarsenPeter Andersen (3 patents)Jens LarsenLars Kyhn Rasmussen (1 patent)Jens LarsenDaniel Rodriguez Greve (1 patent)Jens LarsenMark Andrews (1 patent)Jens LarsenMogens Larsen (1 patent)Jens LarsenAndreas Ritzen (1 patent)Jens LarsenTine Marianne Duus (1 patent)Jens LarsenJens Larsen (8 patents)Simon Feldbaek NielsenSimon Feldbaek Nielsen (22 patents)Xifu LiangXifu Liang (17 patents)Peter AndersenPeter Andersen (4 patents)Lars Kyhn RasmussenLars Kyhn Rasmussen (43 patents)Daniel Rodriguez GreveDaniel Rodriguez Greve (14 patents)Mark AndrewsMark Andrews (5 patents)Mogens LarsenMogens Larsen (5 patents)Andreas RitzenAndreas Ritzen (3 patents)Tine Marianne DuusTine Marianne Duus (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Leo-pharma A/s (4 from 67 patents)

2. Union Therapeutics A/s (4 from 22 patents)


8 patents:

1. 11866445 - Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

2. 11365204 - Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

3. 11299497 - Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

4. 11292799 - Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

5. 11065257 - Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors

6. 10906915 - Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors

7. 10793580 - Substituted pyrazoloazepin-8-ones and their use as phosphodiesterase inhibitors

8. 10703751 - Amino-imidazopyridine derivatives as Janus kinase inhibitors and pharmaceutical use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/11/2025
Loading…